Skip to Main Content

WASHINGTON — A little-known nonprofit established by Congress over 10 years ago to help the Food and Drug Administration work with the private sector is still struggling with a basic question: Where is the cash?

The Reagan-Udall Foundation for the FDA is supposed to act as a liaison between the FDA itself and drug companies, researchers, nonprofits, or other businesses with regulated products who might want to support a project to make the agency’s job easier. It has raised just under $15 million during its first decade, according to the foundation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Well, we saw how these foundations work recently with the NIAAA study to prove alcohol is healthy or at least harmless – enabled by “foundation” money from the liquor lobby. These foundations are no different than PACs (Pharmaceutical Action Committees) where Big Pharma can launder the money to enable studies the government really does not hold in high priority, but that will jump-start sales for some special interest. The researchers and CDC/NIH/FDA can claim no conflict of interest (wink-wink, nudge-nudge); and some university gets a big grant with industry money nicely hidden in plain sight. How could that be a problem?

    • Exactly!
      Foundations like PhRMA get what they pay for. They even “educate” journalists, a clever way to promote the industry while suppressing questions. The Industry trolls have not shown up yet. They tend to overwhelm these sections with glowing endorsements of these foundations or the industry that is no longer accountable.

  • This foundation is pretty irrelevant now. There are plenty of industry insiders “helping” the FDA. These corporations prefer to track their drugs safety in house, so they can deny any problems ever occurred. That way is a lot more profitable, and the information stays proprietary. Every body wins, except for the people taking these over-hyped drugs, and of course the taxpayers that pay for them through Medicare. Even Medicare is not allowed to track any of this, pharma lobbyists told congress that was “Government Overreach.” One fourth of the deaths attributed to opioid overdoses were actually other pharmaceuticals, yet these deaths are not considered a problem for pharma. It was really clever how they got these deaths re-categorized. The same with Adverse Events, reporting those common occurrences is a waste of time, since the FDA ignored the reports on Fentanyl, back in 2008.
    Brain damage, hospital admissions, and death are being deliberately misreported, or unreported, thanks to the criminals at pharma.

Comments are closed.